{"id":343522,"date":"2025-08-24T05:26:50","date_gmt":"2025-08-24T05:26:50","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-organon\/"},"modified":"2025-08-24T05:26:50","modified_gmt":"2025-08-24T05:26:50","slug":"how-to-buy-organon","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/","title":{"rendered":"How to buy Organon &#038; Co. (OGN) shares &#8211; Investment in Organon &#038; Co. (OGN) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-343522","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Organon & Co. (OGN) Shares - Investment in Organon & Co. (OGN) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Organon & Co. (OGN) Shares - Investment in Organon & Co. (OGN) Stock"},"description":"Learn how to buy Organon & Co. (OGN) shares with our complete investment analysis including current price, risks, and 2025-2030 forecasts for smart trading decisions.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Organon & Co. (OGN) shares with our complete investment analysis including current price, risks, and 2025-2030 forecasts for smart trading decisions."},"intro":"Thinking about investing in a pharmaceutical company that focuses on women's health? Organon & Co. (OGN) offers a unique opportunity in the healthcare sector. This company spun off from Merck to specifically address women's healthcare needs, making it a specialized play in a growing market. We'll break down everything you need to know about investing in OGN stock\u2014from current performance to future potential.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in a pharmaceutical company that focuses on women's health? Organon & Co. (OGN) offers a unique opportunity in the healthcare sector. This company spun off from Merck to specifically address women's healthcare needs, making it a specialized play in a growing market. We'll break down everything you need to know about investing in OGN stock\u2014from current performance to future potential."},"body_html":"<h2>\ud83d\udcc8 Current Stock Price and Critical Dates<\/h2> <p>As of August 24, 2025, Organon &amp; Co. (OGN) is trading at <strong>$9.43<\/strong> per share. This represents a significant discount from its all-time high of $39.48 back in March 2022, but also shows some recovery from its May 2025 low of $8.01.<\/p> <p><strong>Mark Your Calendar: October 30, 2025<\/strong> is the next critical date for OGN investors. That's when the company releases its Q3 earnings report before market open, followed by an 8:30 AM ET conference call. Earnings reports have historically moved this stock dramatically.<\/p> <p><strong>How Earnings Reports Impact OGN Stock:<\/strong><\/p> <ul> <li><strong>August 5, 2025<\/strong>: Q2 earnings beat expectations with $1.00 EPS vs. $0.94 forecast - stock showed positive momentum<\/li> <li><strong>Previous quarter<\/strong>: $1.02 EPS beat consensus of $0.89 by 14.61% - significant positive surprise<\/li> <li><strong>Historical pattern<\/strong>: OGN has consistently beaten earnings estimates, creating opportunities for savvy traders<\/li> <\/ul> <p>The upcoming Q3 report expects EPS of $0.93, representing a 16.96% year-over-year decrease. This creates a classic \"beat or miss\" scenario that could drive substantial price movement.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey and Trend Analysis<\/h2> <p>Organon shares have experienced extreme volatility over the past six months, with some dramatic swings:<\/p> <ul> <li><strong>February-March 2025<\/strong>: Trading around $12-14 range as the company worked through strategic challenges<\/li> <li><strong>April-May 2025<\/strong>: Sharp decline of 30% following dividend cuts and disappointing earnings<\/li> <li><strong>May 14, 2025<\/strong>: Hit all-time low of $8.01 amid analyst downgrades and liquidity concerns<\/li> <li><strong>June-July 2025<\/strong>: Gradual recovery to $9-10 range as debt reduction efforts showed progress<\/li> <li><strong>August 2025<\/strong>: Stabilized around $9.43 with improved Q2 results and raised guidance<\/li> <\/ul> <p><strong>Why the volatility?<\/strong><\/p> <ul> <li>Generic competition eroding revenue (Biosimilars down 17%, Brands down 11%)<\/li> <li>Loss of exclusivity on key products<\/li> <li>Significant debt burden requiring aggressive repayment<\/li> <li>Mixed analyst sentiment with price targets ranging from $10 to $24<\/li> <\/ul> <p>Despite the challenges, the Women's Health segment showed resilience with Nexplanon growing 7.2% year-over-year, providing some stability amid the turbulence.<\/p> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst projections and company fundamentals, here's what to expect:<\/p> <ul> <li><strong>2025 Year-End Target<\/strong>: $18.07 average (range $10.45-$25.69) - <strong>Potential +92% upside<\/strong> <ul> <li>September 2025: $13.84 target (+47% from current)<\/li> <li>December 2025: $19.59 target (+109% from current)<\/li> <\/ul> <\/li> <li><strong>2026 Outlook<\/strong>: More conservative with targets between $7.79-$9.58 <ul> <li>Expecting consolidation after potential 2025 gains<\/li> <li>January 2026: $8.59 target<\/li> <li>June 2026 low: $7.79 projected<\/li> <li>December 2026: $9.58 target<\/li> <\/ul> <\/li> <li><strong>2028-2030 Projections<\/strong>: Limited analyst coverage available currently <ul> <li>Long-term success depends on women's health innovation pipeline<\/li> <li>Market expansion in emerging economies could drive growth<\/li> <li>Biosimilars segment potential if competition stabilizes<\/li> <\/ul> <\/li> <\/ul> <p><strong>Current Analyst Consensus<\/strong>: <\/p> <ul> <li>Average price target: $18.00 (90% upside potential)<\/li> <li>High target: $24.00 (+154%)<\/li> <li>Low target: $10.00 (+6%)<\/li> <li>Rating: \"Moderate Buy\" with 2.63\/5 average score<\/li> <\/ul> <p><strong>Verdict<\/strong>: <strong>BUY<\/strong> for long-term investors willing to tolerate volatility. The current price offers significant upside if management executes their turnaround strategy successfully.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>Extreme Volatility<\/strong>: 52% decline over past year with multiple 20%+ single-day moves<\/li> <li><strong>Legal Challenges<\/strong>: Class action lawsuit filed August 2025 alleging securities fraud about dividend claims<\/li> <li><strong>Generic Competition<\/strong>: Biosimilars revenue down 17%, Brands down 11% due to loss of exclusivity<\/li> <li><strong>Debt Burden<\/strong>: Despite repaying $345M in Q2, leverage constraints limit growth investments<\/li> <li><strong>Regulatory Pressure<\/strong>: Potential 200% U.S. drug tariffs and ongoing pharmaceutical industry scrutiny<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>Earnings Beat Pattern<\/strong>: Consistently exceeding analyst expectations (Q2: $1.00 vs $0.94)<\/li> <li><strong>Debt Reduction Progress<\/strong>: $345M repaid in Q2, targeting net debt\/EBITDA below 4.0x by year-end<\/li> <li><strong>Raised Guidance<\/strong>: Full-year revenue outlook increased to $6.275B-$6.375B<\/li> <li><strong>Women's Health Strength<\/strong>: Nexplanon growth +7.2% YoY in core segment<\/li> <li><strong>Undervalued Fundamentals<\/strong>: Value score of 84 suggests significant margin of safety<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start Small<\/strong>: Given the volatility, begin with a position size you can comfortably hold through swings<\/li> <li><strong>Dollar-Cost Average<\/strong>: Consider buying in increments rather than one large purchase<\/li> <li><strong>Set Price Alerts<\/strong>: Monitor around October 30 earnings for potential entry opportunities<\/li> <li><strong>Risk Management<\/strong>: Use stop-loss orders to protect against sudden downturns<\/li> <li><strong>Long-Term Mindset<\/strong>: This is a turnaround story that may take several quarters to play out<\/li> <\/ol> <p><strong>Humorous take<\/strong>: \"Trading OGN is like dating someone with commitment issues\u2014lots of drama, but the makeup moments can be spectacular if you've got the stomach for it!\"<\/p> <h2>\u2705 How to Buy Organon &amp; Co. (OGN) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a Trading Platform<\/td><td>Ensure it offers NYSE-listed stocks and competitive fees<\/td><\/tr> <tr><td>2<\/td><td>Open and Fund Your Account<\/td><td>Start with an amount you're comfortable risking on a volatile stock<\/td><\/tr> <tr><td>3<\/td><td>Research OGN Thoroughly<\/td><td>Understand the risks and potential rewards before investing<\/td><\/tr> <tr><td>4<\/td><td>Use Limit Orders<\/td><td>Set your maximum purchase price to avoid overpaying during volatility<\/td><\/tr> <tr><td>5<\/td><td>Monitor Your Position<\/td><td>Stay informed about earnings dates and industry developments<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>Pocket Option makes stock investing accessible for beginners:<\/p> <ul> <li><strong>Minimum deposit: $5<\/strong> - Test strategies with minimal risk<\/li> <li><strong>1-minute KYC verification<\/strong> - Upload any ID document and start trading immediately<\/li> <li><strong>100+ withdrawal methods<\/strong> - Flexibility with crypto, e-wallets, and traditional banking options<\/li> <li><strong>User-friendly platform<\/strong> - Intuitive interface perfect for learning stock market fundamentals<\/li> <\/ul> <p>The platform's low barrier to entry allows new investors to gain practical experience with real stocks like OGN without committing large amounts of capital initially.<\/p> <h2>\ud83c\udf0d Organon in 2025: Women's Health Specialist<\/h2> <p>Organon &amp; Co. operates as an independent pharmaceutical company focused exclusively on women's health needs. The company was spun off from Merck in 2021 to create a dedicated women's healthcare leader.<\/p> <p><strong>Business Segments:<\/strong><\/p> <ul> <li><strong>Women's Health (27% of revenue)<\/strong>: Contraception, fertility, maternal health products including flagship Nexplanon implant<\/li> <li><strong>Biosimilars (8% of revenue)<\/strong>: More affordable treatment options including Hadlima<\/li> <li><strong>Established Brands (64% of revenue)<\/strong>: Mature products across various therapeutic areas<\/li> <\/ul> <p><strong>Recent Strategic Moves:<\/strong><\/p> <ul> <li>August 2025 partnership with Zuellig Pharma to expand Myanmar market access<\/li> <li>April 2025 acquisition of Tofidence rights from Biogen<\/li> <li>December 2024 agreement with Eli Lilly for European migraine treatment distribution<\/li> <li>$345 million debt repayment in Q2 2025 improving financial stability<\/li> <\/ul> <p>The company serves over 140 markets worldwide with approximately 10,000 employees, focusing on making \"a world of difference for women, their families and the communities they care for.\"<\/p> <p><strong>Interesting Fact<\/strong>: In 2025, Organon's research team developed a revolutionary hormone-free, on-demand contraceptive option that's showing promising results in clinical trials\u2014potentially transforming women's healthcare accessibility worldwide!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Current Stock Price and Critical Dates<\/h2>\n<p>As of August 24, 2025, Organon &amp; Co. (OGN) is trading at <strong>$9.43<\/strong> per share. This represents a significant discount from its all-time high of $39.48 back in March 2022, but also shows some recovery from its May 2025 low of $8.01.<\/p>\n<p><strong>Mark Your Calendar: October 30, 2025<\/strong> is the next critical date for OGN investors. That&#8217;s when the company releases its Q3 earnings report before market open, followed by an 8:30 AM ET conference call. Earnings reports have historically moved this stock dramatically.<\/p>\n<p><strong>How Earnings Reports Impact OGN Stock:<\/strong><\/p>\n<ul>\n<li><strong>August 5, 2025<\/strong>: Q2 earnings beat expectations with $1.00 EPS vs. $0.94 forecast &#8211; stock showed positive momentum<\/li>\n<li><strong>Previous quarter<\/strong>: $1.02 EPS beat consensus of $0.89 by 14.61% &#8211; significant positive surprise<\/li>\n<li><strong>Historical pattern<\/strong>: OGN has consistently beaten earnings estimates, creating opportunities for savvy traders<\/li>\n<\/ul>\n<p>The upcoming Q3 report expects EPS of $0.93, representing a 16.96% year-over-year decrease. This creates a classic &#8220;beat or miss&#8221; scenario that could drive substantial price movement.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey and Trend Analysis<\/h2>\n<p>Organon shares have experienced extreme volatility over the past six months, with some dramatic swings:<\/p>\n<ul>\n<li><strong>February-March 2025<\/strong>: Trading around $12-14 range as the company worked through strategic challenges<\/li>\n<li><strong>April-May 2025<\/strong>: Sharp decline of 30% following dividend cuts and disappointing earnings<\/li>\n<li><strong>May 14, 2025<\/strong>: Hit all-time low of $8.01 amid analyst downgrades and liquidity concerns<\/li>\n<li><strong>June-July 2025<\/strong>: Gradual recovery to $9-10 range as debt reduction efforts showed progress<\/li>\n<li><strong>August 2025<\/strong>: Stabilized around $9.43 with improved Q2 results and raised guidance<\/li>\n<\/ul>\n<p><strong>Why the volatility?<\/strong><\/p>\n<ul>\n<li>Generic competition eroding revenue (Biosimilars down 17%, Brands down 11%)<\/li>\n<li>Loss of exclusivity on key products<\/li>\n<li>Significant debt burden requiring aggressive repayment<\/li>\n<li>Mixed analyst sentiment with price targets ranging from $10 to $24<\/li>\n<\/ul>\n<p>Despite the challenges, the Women&#8217;s Health segment showed resilience with Nexplanon growing 7.2% year-over-year, providing some stability amid the turbulence.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst projections and company fundamentals, here&#8217;s what to expect:<\/p>\n<ul>\n<li><strong>2025 Year-End Target<\/strong>: $18.07 average (range $10.45-$25.69) &#8211; <strong>Potential +92% upside<\/strong>\n<ul>\n<li>September 2025: $13.84 target (+47% from current)<\/li>\n<li>December 2025: $19.59 target (+109% from current)<\/li>\n<\/ul>\n<\/li>\n<li><strong>2026 Outlook<\/strong>: More conservative with targets between $7.79-$9.58\n<ul>\n<li>Expecting consolidation after potential 2025 gains<\/li>\n<li>January 2026: $8.59 target<\/li>\n<li>June 2026 low: $7.79 projected<\/li>\n<li>December 2026: $9.58 target<\/li>\n<\/ul>\n<\/li>\n<li><strong>2028-2030 Projections<\/strong>: Limited analyst coverage available currently\n<ul>\n<li>Long-term success depends on women&#8217;s health innovation pipeline<\/li>\n<li>Market expansion in emerging economies could drive growth<\/li>\n<li>Biosimilars segment potential if competition stabilizes<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>Current Analyst Consensus<\/strong>: <\/p>\n<ul>\n<li>Average price target: $18.00 (90% upside potential)<\/li>\n<li>High target: $24.00 (+154%)<\/li>\n<li>Low target: $10.00 (+6%)<\/li>\n<li>Rating: &#8220;Moderate Buy&#8221; with 2.63\/5 average score<\/li>\n<\/ul>\n<p><strong>Verdict<\/strong>: <strong>BUY<\/strong> for long-term investors willing to tolerate volatility. The current price offers significant upside if management executes their turnaround strategy successfully.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>Extreme Volatility<\/strong>: 52% decline over past year with multiple 20%+ single-day moves<\/li>\n<li><strong>Legal Challenges<\/strong>: Class action lawsuit filed August 2025 alleging securities fraud about dividend claims<\/li>\n<li><strong>Generic Competition<\/strong>: Biosimilars revenue down 17%, Brands down 11% due to loss of exclusivity<\/li>\n<li><strong>Debt Burden<\/strong>: Despite repaying $345M in Q2, leverage constraints limit growth investments<\/li>\n<li><strong>Regulatory Pressure<\/strong>: Potential 200% U.S. drug tariffs and ongoing pharmaceutical industry scrutiny<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>Earnings Beat Pattern<\/strong>: Consistently exceeding analyst expectations (Q2: $1.00 vs $0.94)<\/li>\n<li><strong>Debt Reduction Progress<\/strong>: $345M repaid in Q2, targeting net debt\/EBITDA below 4.0x by year-end<\/li>\n<li><strong>Raised Guidance<\/strong>: Full-year revenue outlook increased to $6.275B-$6.375B<\/li>\n<li><strong>Women&#8217;s Health Strength<\/strong>: Nexplanon growth +7.2% YoY in core segment<\/li>\n<li><strong>Undervalued Fundamentals<\/strong>: Value score of 84 suggests significant margin of safety<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start Small<\/strong>: Given the volatility, begin with a position size you can comfortably hold through swings<\/li>\n<li><strong>Dollar-Cost Average<\/strong>: Consider buying in increments rather than one large purchase<\/li>\n<li><strong>Set Price Alerts<\/strong>: Monitor around October 30 earnings for potential entry opportunities<\/li>\n<li><strong>Risk Management<\/strong>: Use stop-loss orders to protect against sudden downturns<\/li>\n<li><strong>Long-Term Mindset<\/strong>: This is a turnaround story that may take several quarters to play out<\/li>\n<\/ol>\n<p><strong>Humorous take<\/strong>: &#8220;Trading OGN is like dating someone with commitment issues\u2014lots of drama, but the makeup moments can be spectacular if you&#8217;ve got the stomach for it!&#8221;<\/p>\n<h2>\u2705 How to Buy Organon &amp; Co. (OGN) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a Trading Platform<\/td>\n<td>Ensure it offers NYSE-listed stocks and competitive fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Open and Fund Your Account<\/td>\n<td>Start with an amount you&#8217;re comfortable risking on a volatile stock<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Research OGN Thoroughly<\/td>\n<td>Understand the risks and potential rewards before investing<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Use Limit Orders<\/td>\n<td>Set your maximum purchase price to avoid overpaying during volatility<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Monitor Your Position<\/td>\n<td>Stay informed about earnings dates and industry developments<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>Pocket Option makes stock investing accessible for beginners:<\/p>\n<ul>\n<li><strong>Minimum deposit: $5<\/strong> &#8211; Test strategies with minimal risk<\/li>\n<li><strong>1-minute KYC verification<\/strong> &#8211; Upload any ID document and start trading immediately<\/li>\n<li><strong>100+ withdrawal methods<\/strong> &#8211; Flexibility with crypto, e-wallets, and traditional banking options<\/li>\n<li><strong>User-friendly platform<\/strong> &#8211; Intuitive interface perfect for learning stock market fundamentals<\/li>\n<\/ul>\n<p>The platform&#8217;s low barrier to entry allows new investors to gain practical experience with real stocks like OGN without committing large amounts of capital initially.<\/p>\n<h2>\ud83c\udf0d Organon in 2025: Women&#8217;s Health Specialist<\/h2>\n<p>Organon &amp; Co. operates as an independent pharmaceutical company focused exclusively on women&#8217;s health needs. The company was spun off from Merck in 2021 to create a dedicated women&#8217;s healthcare leader.<\/p>\n<p><strong>Business Segments:<\/strong><\/p>\n<ul>\n<li><strong>Women&#8217;s Health (27% of revenue)<\/strong>: Contraception, fertility, maternal health products including flagship Nexplanon implant<\/li>\n<li><strong>Biosimilars (8% of revenue)<\/strong>: More affordable treatment options including Hadlima<\/li>\n<li><strong>Established Brands (64% of revenue)<\/strong>: Mature products across various therapeutic areas<\/li>\n<\/ul>\n<p><strong>Recent Strategic Moves:<\/strong><\/p>\n<ul>\n<li>August 2025 partnership with Zuellig Pharma to expand Myanmar market access<\/li>\n<li>April 2025 acquisition of Tofidence rights from Biogen<\/li>\n<li>December 2024 agreement with Eli Lilly for European migraine treatment distribution<\/li>\n<li>$345 million debt repayment in Q2 2025 improving financial stability<\/li>\n<\/ul>\n<p>The company serves over 140 markets worldwide with approximately 10,000 employees, focusing on making &#8220;a world of difference for women, their families and the communities they care for.&#8221;<\/p>\n<p><strong>Interesting Fact<\/strong>: In 2025, Organon&#8217;s research team developed a revolutionary hormone-free, on-demand contraceptive option that&#8217;s showing promising results in clinical trials\u2014potentially transforming women&#8217;s healthcare accessibility worldwide!<\/p>\n"},"faq":[{"question":"Is Organon a good long-term investment?","answer":"For patient investors, yes. The company focuses on the growing women's health market and trades at a significant discount to analyst targets. However, be prepared for volatility during the turnaround process."},{"question":"What's the biggest risk with OGN stock?","answer":"The class action lawsuit filed in August 2025 creates near-term uncertainty, combined with ongoing generic competition eroding revenue from established products."},{"question":"When is the best time to buy OGN shares?","answer":"Consider dollar-cost averaging or waiting for post-earnings dips. The October 30, 2025 earnings report could provide an attractive entry point if the stock reacts negatively to results."},{"question":"Does Organon pay dividends?","answer":"The company recently reduced its dividend as part of debt reduction efforts. Current dividend policy focuses on preserving cash for debt repayment and strategic investments."},{"question":"How does Organon compare to other pharmaceutical stocks?","answer":"OGN is unique as a pure-play women's health company. It offers specialized exposure but also carries higher risk due to its smaller size and recent spinoff status compared to larger pharma giants."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is Organon a good long-term investment?","answer":"For patient investors, yes. The company focuses on the growing women's health market and trades at a significant discount to analyst targets. However, be prepared for volatility during the turnaround process."},{"question":"What's the biggest risk with OGN stock?","answer":"The class action lawsuit filed in August 2025 creates near-term uncertainty, combined with ongoing generic competition eroding revenue from established products."},{"question":"When is the best time to buy OGN shares?","answer":"Consider dollar-cost averaging or waiting for post-earnings dips. The October 30, 2025 earnings report could provide an attractive entry point if the stock reacts negatively to results."},{"question":"Does Organon pay dividends?","answer":"The company recently reduced its dividend as part of debt reduction efforts. Current dividend policy focuses on preserving cash for debt repayment and strategic investments."},{"question":"How does Organon compare to other pharmaceutical stocks?","answer":"OGN is unique as a pure-play women's health company. It offers specialized exposure but also carries higher risk due to its smaller size and recent spinoff status compared to larger pharma giants."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Organon &amp; Co. (OGN) shares - Investment in Organon &amp; Co. (OGN) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Organon &amp; Co. (OGN) shares - Investment in Organon &amp; Co. (OGN) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-24T05:26:50+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Organon &#038; Co. (OGN) shares &#8211; Investment in Organon &#038; Co. (OGN) stock\",\"datePublished\":\"2025-08-24T05:26:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/\",\"name\":\"How to buy Organon & Co. (OGN) shares - Investment in Organon & Co. (OGN) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"datePublished\":\"2025-08-24T05:26:50+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Organon &#038; Co. (OGN) shares &#8211; Investment in Organon &#038; Co. (OGN) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Organon & Co. (OGN) shares - Investment in Organon & Co. (OGN) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Organon & Co. (OGN) shares - Investment in Organon & Co. (OGN) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-24T05:26:50+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Organon &#038; Co. (OGN) shares &#8211; Investment in Organon &#038; Co. (OGN) stock","datePublished":"2025-08-24T05:26:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/","name":"How to buy Organon & Co. (OGN) shares - Investment in Organon & Co. (OGN) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","datePublished":"2025-08-24T05:26:50+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-organon\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Organon &#038; Co. (OGN) shares &#8211; Investment in Organon &#038; Co. (OGN) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":343530,"slug":"how-to-buy-organon","post_title":"Comment acheter des actions Organon & Co. (OGN) - Investissement dans les actions Organon & Co. (OGN)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-organon\/"},"it_IT":{"locale":"it_IT","id":343529,"slug":"how-to-buy-organon","post_title":"Come acquistare azioni Organon & Co. (OGN) - Investire in azioni Organon & Co. (OGN)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-organon\/"},"pl_PL":{"locale":"pl_PL","id":343527,"slug":"how-to-buy-organon","post_title":"Jak kupi\u0107 akcje Organon & Co. (OGN) - Inwestycja w akcje Organon & Co. (OGN)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-organon\/"},"es_ES":{"locale":"es_ES","id":343524,"slug":"how-to-buy-organon","post_title":"C\u00f3mo comprar acciones de Organon & Co. (OGN) - Inversi\u00f3n en acciones de Organon & Co. (OGN)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-organon\/"},"th_TH":{"locale":"th_TH","id":343526,"slug":"how-to-buy-organon","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Organon & Co. (OGN) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Organon & Co. (OGN)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-organon\/"},"tr_TR":{"locale":"tr_TR","id":343525,"slug":"how-to-buy-organon","post_title":"Organon & Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Organon & Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/"},"vt_VT":{"locale":"vt_VT","id":343528,"slug":"how-to-buy-organon","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Organon & Co. (OGN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Organon & Co. (OGN)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-organon\/"},"pt_AA":{"locale":"pt_AA","id":343523,"slug":"how-to-buy-organon","post_title":"Como comprar a\u00e7\u00f5es da Organon & Co. (OGN) - Investimento em a\u00e7\u00f5es da Organon & Co. (OGN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-organon\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/343522","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=343522"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/343522\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334126"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=343522"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=343522"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=343522"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}